Role of cyclooxygenase 2 in acute spinal cord injury - PubMed (original) (raw)

Role of cyclooxygenase 2 in acute spinal cord injury

D K Resnick et al. J Neurotrauma. 1998 Dec.

Abstract

Cyclooxygenase, or prostaglandin G/H synthase, is the rate-limiting step in the production of prostaglandins. A new isoform, cyclooxygenase-2 (COX-2), has been cloned that is induced during inflammation in leukocytes and by synaptic activity in neurons. The objectives of this study are to determine the nature of COX-2 expression in normal and traumatized rat spinal cord, and to determine the effects of selective COX-2 inhibition on functional recovery following spinal cord injury. Using a weight-drop model of spinal cord injury, COX-2 mRNA expression was studied with in situ hybridization. COX-2 protein expression was examined by immunohistochemistry and Western analysis. Finally, using the highly selective COX-2 inhibitor, 1-[(4-methylsufonyl)phenyl]-3-tri-fluro-methyl-5-[(4-flur o)phenyl]prazole (SC58125), the effect of COX-2 inhibition on functional outcome following a spinal cord injury was determined. COX-2 was expressed in the normal adult rat spinal cord. COX-2 mRNA and protein production were increased following injury with increases in COX-2 mRNA production detectable at 2 h following injury. Increased levels of COX-2 protein were detectable for at least 48 h following traumatic spinal cord injury. Selective inhibition of COX-2 activity with SC58125 resulted in improved mean Basso, Beattie, and Bresnahan scores in animals with 12.5- and 25-g/cm spinal cord injuries; however, the effect was significant only for the 12.5g/cm injury group (p=0.0001 vs. p=0.0643 in the 25-g/cm group). These data demonstrate that COX-2 mRNA and protein expression are induced by spinal cord injury, and that selective inhibition of COX-2 improves functional outcome following experimental spinal cord injury.

PubMed Disclaimer

Cited by

Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma.
Zhang HJ, Chen YT, Hu XL, Cai WT, Wang XY, Ni WF, Zhou KL. Zhang HJ, et al. Neural Regen Res. 2023 Feb;18(2):258-266. doi: 10.4103/1673-5374.346460. Neural Regen Res. 2023. PMID: 35900400 Free PMC article. Review.
Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge.
An Y, Belevych N, Wang Y, Zhang H, Herschman H, Chen Q, Quan N. An Y, et al. J Neurosci Res. 2014 Apr;92(4):486-95. doi: 10.1002/jnr.23317. Epub 2013 Dec 24. J Neurosci Res. 2014. PMID: 24375716 Free PMC article.
Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat.
Khalatbary AR, Ahmadvand H. Khalatbary AR, et al. Iran Biomed J. 2011;15(1-2):31-7. Iran Biomed J. 2011. PMID: 21725497 Free PMC article.
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, Banati RR, Anand P. Yiangou Y, et al. BMC Neurol. 2006 Mar 2;6:12. doi: 10.1186/1471-2377-6-12. BMC Neurol. 2006. PMID: 16512913 Free PMC article.
Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.
Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, Zhang JH. Fathali N, et al. Crit Care Med. 2010 Feb;38(2):572-8. doi: 10.1097/CCM.0b013e3181cb1158. Crit Care Med. 2010. PMID: 20029340 Free PMC article.

Role of cyclooxygenase 2 in acute spinal cord injury - PubMed (original) (raw)